1. "Future Medicine"
Formats
  1. Journal Article (143)
  2. Review (28)
  3. Book Section (11)
  4. Editorial (4)
  5. Book Whole (3)
  6. Correspondence (1)
Groups
  1. Department of Medicine (90)
  2. Solid Tumor Oncology Division (69)
  3. Surgery (27)
  4. Hematologic Malignancies, Division of (23)
  5. Survivorship Research (22)
  6. Population Sciences Research Program (20)

More Groups

People
  1. Amitabh Gulati (9)
  2. Yelena Janjigian (6)
  3. Robert Motzer (5)
  4. Ghassan Abou-Alfa (4)
  5. Susan Slovin (4)
  6. Tiffany Traina (4)

More People

Years
  1. 2023 (17)
  2. 2022 (16)
  3. 2021 (21)
  4. 2020 (7)
  5. 2019 (10)
  6. 2018 (10)

More Years

Publications
  1. Future Oncology (86)
  2. Immunotherapy (21)
  3. CNS Oncology (9)
  4. Pain Management (8)
  5. Imaging in Medicine (5)
  6. Advances in the Management of Triple-Negative Breast Cancer (4)

More Publications

Publishers
  1. Future Medicine (190)

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors
    Review

    Baskaran, A. B.; Bhatia, A.; Kumthekar, P.; Boire, A.; Lukas, R. V.
    Future Oncology (2023)

    Fulltext@MSK | Save
  • HERTHENA-Lung01: A phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC
    Review

    Yu, H. A.; Yang, J. C. H.; Hayashi, H.; Goto, Y.; Felip, E.; Reck, M.; Vigliotti, M.; Dong, Q.; Cantero, F.; Fan, P. D.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
    Journal Article

    Krishnan, A.; Nooka, A. K.; Chari, A.; Garfall, A. L.; Martin, T. G.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; more...
    Journal of Comparative Effectiveness Research (2023)

    Fulltext@MSK | Save
  • A plain language summary of the CheckMate 649 study: Nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
    Review

    Janjigian, Y. Y.; Shitara, K.; Moehler, M.; Garrido, M.; Salman, P.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma
    Review

    Moreau, P.; van de Donk, N. W. C. J.; Nahi, H.; Oriol, A.; Nooka, A. K.; Martin, T.; Rosinol, L.; Karlin, L.; Benboubker, L.; Mateos, M. V.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Brightline-1: Phase II/III trial of the MDM2–p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS
    Review

    Schöffski, P.; Lahmar, M.; Lucarelli, A.; Maki, R. G.
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Plain language summary of the development of tepotinib: A treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping
    Review

    Hallick, J.; Baird, A. M.; Falchook, G.; Le, X.; Hong, D.; Viteri, S.; Raskin, J.; Reinmuth, N.; Vlassak, S.; Militaru, M.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): A plain language summary
    Review

    Bajorin, D. F.; Witjes, J. A.; Gschwend, J. E.; Schenker, M.; Valderrama, B. P.; Tomita, Y.; Bamias, A.; Lebret, T.; Shariat, S. F.; Park, S. H.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Plain language summary of the iNNOVATE study: Ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia
    Review

    Buske, C.; Tedeschi, A.; Trotman, J.; García-Sanz, R.; MacDonald, D.; Leblond, V.; Mahe, B.; Herbaux, C.; Matous, J. V.; Tam, C. S.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: A meta-regression
    Journal Article

    Malik, A.; Jairam, M. P.; Chow, R.; Mirshahvalad, S. A.; Veit-Haibach, P.; Simone, C. B. 2nd
    Future Oncology (2023)

    Fulltext@MSK | Save